We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.06B
AUM Growth
+$442M
Cap. Flow
+$399M
Cap. Flow %
19.35%
Top 10 Hldgs %
32.73%
Holding
584
New
175
Increased
109
Reduced
81
Closed
182

Sector Composition

Rank Sector Weight
1 Real Estate 25.91%
2 Consumer Discretionary 8.43%
3 Financials 6.54%
4 Industrials 6%
5 Utilities 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELGX
376
DELISTED
Endologix Inc
ELGX
$240K 0.01%
+4,200
New +$385K
GRA
377
DELISTED
W.R. Grace & Co.
GRA
$233K 0.01%
3,450
-35,454
-91% -$2.42M
OCRX
378
DELISTED
Ocera Therapeutics, Inc.
OCRX
$231K 0.01%
110,000
BLDR icon
379
Builders FirstSource
BLDR
$7.84B
$219K 0.01%
20,000
-5,000
-20% -$54.2K
MZOR
380
DELISTED
Mazor Robotics Ltd.
MZOR
$219K 0.01%
10,000
-1,500
-13% -$33.8K
ICPT
381
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$217K 0.01%
2,000
DGAZ
382
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
$212K 0.01%
700
ABT icon
383
Abbott
ABT
$180B
$201K 0.01%
5,241
+27
+0.5% +$1.07K
INSY
384
DELISTED
Insys Therapeutics, Inc.
INSY
$193K 0.01%
21,000
MCHX icon
385
Marchex
MCHX
$79.7M
$169K 0.01%
+63,648
New +$168K
RIGL icon
386
Rigel Pharmaceuticals
RIGL
$680M
$167K 0.01%
7,000
-500
-7% -$14.3K
PRTK
387
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$154K 0.01%
+10,000
New +$130K
EXEL icon
388
CALL
Exelixis
EXEL
$13.9B
$149K 0.01%
10,000
-20,000
-67% -$289K
EXEL icon
389
Exelixis
EXEL
$13.9B
$149K 0.01%
10,000
-16,000
-62% -$231K
TGTX icon
390
TG Therapeutics
TGTX
$8.58B
$140K 0.01%
30,000
HIND
391
Vyome Holdings
HIND
$14.5M
0
TTOO
392
DELISTED
T2 Biosystems, Inc
TTOO
$132K 0.01%
5
TVRD
393
Tvardi Therapeutics
TVRD
$23.5M
$93K ﹤0.01%
+278
New +$89.2K
ALIM
394
DELISTED
Alimera Sciences
ALIM
$92K ﹤0.01%
5,667
CERS icon
395
Cerus
CERS
$587M
$87K ﹤0.01%
20,000
QURE icon
396
uniQure
QURE
$2.68B
$84K ﹤0.01%
+15,000
New +$101K
CPRX
397
DELISTED
Catalyst Pharmaceutical
CPRX
$71K ﹤0.01%
68,000
TRAW icon
398
Traws Pharma
TRAW
$7.43M
$55K ﹤0.01%
4
FOLD
399
DELISTED
Amicus Therapeutics
FOLD
$50K ﹤0.01%
10,000
CEMP
400
CALL
DELISTED
Cempra, Inc.
CEMP
$42K ﹤0.01%
+15,000
New +$182K

Similar funds

Weiss Multi-Strategy Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, Weiss Multi-Strategy Advisers held 584 positions worth $2.06B, up 27% from $1.62B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Weiss Multi-Strategy Advisers deployed $399M of net new capital in Q4 2016, opening 175 new positions and adding to 109 existing holdings. Its largest new stake was Boston Properties: 455,075 shares worth $57.2M.

By sector, the portfolio is most concentrated in Real Estate at 26% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Foot Locker, an estimated $15.1M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q4 2016 buy was Boston Properties: 455,075 shares worth $57.2M.
  • Weiss Multi-Strategy Advisers added most to State Street SPDR S&P 500 ETF Trust in Q4 2016, an estimated $307M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2016 reduction was Foot Locker, cutting an estimated $15.1M.
  • Weiss Multi-Strategy Advisers fully exited Liberty Property Trust in Q4 2016, selling an estimated $17.6M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 33% of its $2.06B portfolio in Q4 2016.
  • Weiss Multi-Strategy Advisers opened 175 new positions and closed 182 in Q4 2016.
  • Weiss Multi-Strategy Advisers's portfolio value rose 27% quarter-over-quarter to $2.06B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.